Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat vs Darbepoetin alfa in NDD-CKD Anemia (PRO2TECT-CONVERSION)
NCT02680574Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- Feb 2016
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 30
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started Feb 2016; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02680574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680574.